Bimekizumab Maintained Efficacy Responses in Patients with Active Psoriatic Arthritis: Up to 2-Year Results from Two Phase 3 Studies

被引：0
|
作者：
Walsh, Jessica A. [1 ,2 ]
Merola, Joseph F. [3 ]
Ritchlin, Christopher T. [4 ]
Tanaka, Yoshiya [5 ]
Favalli, Ennio Giulio [6 ]
McGonagle, Dennis [7 ]
Thaci, Diamant [8 ]
Ink, Barbara [9 ]
Bajracharya, Rajan [9 ]
Coarse, Jason [10 ]
Tillett, William [11 ,12 ]
机构：
[1] Salt Lake City Vet Affairs Hlth, Div Rheumatol, Salt Lake City, UT USA
[2] Univ Utah Hlth, Salt Lake City, UT USA
[3] UT Southwestern Med Ctr, Dallas, TX USA
[4] Univ Rochester, Sch Med, Allergy Immunol & Rheumatol Div, Rochester, NY USA
[5] Univ Occupat & Environm Hlth, Dept Internal Med, Kitakyushu, Fukuoka, Japan
[6] ASST Gaetano Pini CTO, Milan, Lombardia, Italy
[7] Leeds Teaching Hosp, Leeds Biomed Res Ctr BRC, NIHR, Leeds, W Yorkshire, England
[8] Univ Lubeck, Inst & Comprehens Ctr Inflammat Med, Lubeck, Schleswig Holst, Germany
[9] UCB Pharma, Slough, Berks, England
[10] UCB Pharma, Morrisville, NC USA
[11] Royal Natl Hosp Rheumat Dis, Bath, Avon, England
[12] Univ Bath, Dept Life Sci, Ctr Therapeut Innovat, Bath, Avon, England
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
0591
引用
收藏
页码：1206 / 1209
页数：4
相关论文
共 50 条
  • [1] BIMEKIZUMAB EFFICACY AND SAFETY IN PATIENTS WITH PSORIATIC ARTHRITIS AND PSORIASIS: UP TO 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
    Thaci, Diamant
    Gottlieb, Alice B.
    Asahina, Akihiko
    Lebwohl, Mark
    McInnes, Iain B.
    Warren, Richard
    Boehncke, Wolf-Henning
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Merola, Joseph F.
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [2] Safety and Efficacy of Bimekizumab in Patients with Psoriatic Arthritis: 2-Year Results from Two Phase 3 Studies
    Mease, Philip J.
    Merola, Joseph F.
    Tanaka, Yoshiya
    Gossec, Laure
    Mcinnes, Iain B.
    Ritchlin, Christopher T.
    Landewe, Robert B. M.
    Asahina, Akihiko
    Ink, Barbara
    Heinrichs, Andrea
    Bajracharya, Rajan
    Shende, Vishvesh
    Coarse, Jason
    Coates, Laura C.
    RHEUMATOLOGY AND THERAPY, 2024, 11 (05) : 1363 - 1382
  • [3] BIMEKIZUMAB REDUCED PSORIATIC ARTHRITIS IMPACT IN PATIENTS WITH PSORIASIS: UP TO 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
    Gossec, Laure
    Gladman, Dafna D.
    Gisondi, Paolo
    de Wit, Maarten
    Ogdie, Alexis
    Ink, Barbara
    Taieb, Vanessa
    Lambert, Jeremy
    Coates, Laura C.
    ACTA DERMATO-VENEREOLOGICA, 2024, 104
  • [4] BIMEKIZUMAB DELIVERED SUSTAINED IMPROVEMENTS IN EFFICACY AND DEMONSTRATED A CONSISTENT SAFETY PROFILE IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS: UP TO 2-YEAR RESULTS FROM TWO PHASE 3 STUDIES
    Mease, P. J.
    Merola, J. F.
    Landewe, R.
    McInnes, I. B.
    Ritchlin, C. T.
    Tanaka, Y.
    Asahina, A.
    Gossec, L.
    Ink, B.
    Heinrichs, A.
    Bajracharya, R.
    Shende, V
    Coarse, J.
    Coates, L. C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 98 - 99
  • [5] Bimekizumab-Treated Patients with Active Psoriatic Arthritis Showed Sustained Improvements in Pain and Fatigue: Up to 2-Year Results from Two Phase 3 Studies
    Mease, Philip
    Tillett, William
    de Wit, Maarten
    Gossec, Laure
    Husni, M. Elaine
    Proft, Fabian
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Lambert, Jeremy
    Coates, Laura
    Gottlieb, Alice
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 4789 - 4792
  • [6] Bimekizumab-treated patients with active psoriatic arthritis showed sustained achievement of minimal disease activity and remission: Up to 2-year results from two phase 3 studies
    Coates, L. C.
    Kristensen, L. E.
    Ogdie, A.
    Tillett, W.
    Ink, B.
    Goldammer, N.
    Bajracharya, R.
    Coarse, J.
    Orbai, A. M.
    SWISS MEDICAL WEEKLY, 2024, 154 : 35S - 35S
  • [7] Bimekizumab-Treated Patients with Active Psoriatic Arthritis Showed Sustained Reductions in Disease Impact Assessed by the Psoriatic Arthritis Impact of Disease (PsAID)-12 Questionnaire: Up to 2-Year Results from Two Phase 3 Studies
    Gossec, Laure
    Gladman, Dafna
    Coates, Laura
    de Wit, Maarten
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Lambert, Jeremy
    Orbai, Ana-Maria
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1228 - 1232
  • [8] Efficacy and Safety of Bimekizumab in Patients With Psoriatic Arthritis With or Without Methotrexate: 52-Week Results From Two Phase 3 Studies
    McInnes, Iain B.
    Mease, Philip J.
    Tanaka, Yoshiya
    Gossec, Laure
    Husni, M. Elaine
    Kristensen, Lars Erik
    Warren, Richard B.
    Ink, Barbara
    Bajracharya, Rajan
    Coarse, Jason
    Gottlieb, Alice B.
    ACR OPEN RHEUMATOLOGY, 2024, 6 (11) : 720 - 731
  • [9] Long-term safety and efficacy of bimekizumab in axial spondyloarthritis: 2-year results from two phase 3 studies
    Baraliakos, Xenofon
    Deodhar, Atul
    van der Heijde, Desiree
    van den Bosch, Filip
    Magrey, Marina
    Maksymowych, Walter P.
    Tomita, Tetsuya
    Xu, Huji
    Massow, Ute
    Vaux, Tom
    Prajapati, Chetan
    Manente, Myriam
    Marten, Alexander
    Gensler, Lianne S.
    RHEUMATOLOGY, 2025,
  • [10] Bimekizumab Maintained Stringent Clinical Responses over 2 Years in Patients with Axial Spondyloarthritis: Results from Two Phase 3 Studies
    Proft, Fabian
    Van der Heijde, Desiree
    Schwartzman, Sergio
    Ermann, Joerg
    Marten, Alexander
    Massow, Ute
    Stojan, George
    Taieb, Vanessa
    Voiniciuc, Diana
    Van Tubergen, Astrid
    Compan, Victoria Navarro
    Baraliakos, Xenofon
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 1221 - 1223
12345